Australian National Duchenne Muscular Dystrophy Registry

The Australian Duchenne Muscular Dystrophy Registry is linked directly to the TREAT-NMD global network of registries, an international effort which has proven effective in improving the health and management of boys with DMD. The Registry provides an important enabling tool for clinicians and clinical trial sponsors to quickly identify patients suitable for each study, particularly those therapeutic strategies that target specific genetic defects.

Potential Benefits of a DMD Registry

• Centralise information and provide an interface between patients, doctors and researchers
• Coordination of diagnosis, therapy and prevention – universally available across Australia
• Promote sense of community and belonging among affected patients and families and provide ready access to information concerning standards of care, research and available therapies
• Monitor and benchmark data to improve health care performance across institutions and providers
• Promote baseline standards of care available to all patients and families – provision of the “right care at the right time”
• Provide essential information necessary to leverage government and industrial support for further infrastructure

Robin Forbes

Co-ordinator

Australian Neuromuscular Disease Registry

P: +61 3 9936 6740

E: anmdr@mcri.edu.au

The database is open to anyone affected by DMD and is entirely voluntary – data obtained is held securely and confidentially. Clinical and genetic information about each patient will be entered by Registry staff

Details on how to register can be found on the website

W: Australiannmdregistry.org.au